Maintenance ribavirin monotherapy delays fibrosis progression in liver transplant recipients with recurrent hepatitis C at high risk of progression
To access this article, please choose from the options below
PII: S1590-8658(09)00367-3
doi:10.1016/j.dld.2009.08.008
© 2009 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Inc All rights reserved.
